DailySand tracks Schedule III across AI, semiconductor infrastructure, capital markets, and critical minerals supply chains. Below are curated source items and daily digests where Schedule III appears in today's cross-sector intelligence briefing.
2 items across 4 digests
The U.S. Drug Enforcement Administration will hold a June 29 administrative hearing to evaluate broader cannabis rescheduling beyond the Schedule III medical classification finalized earlier. Resolution impacts federal-state regulatory alignment and capital availability for cannabis-adjacent agricultural and processing infrastructure.
Read original →The DEA will hold an administrative hearing on June 29 to consider broader rescheduling of cannabis beyond the state-licensed medical market to Schedule III status, which would affect the entire adult-use commerce sector. This regulatory decision carries material implications for investment in cannabis-adjacent industries and compliance costs across supply chains.
Read original →
DailySand